Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News New non-invasive glaucoma therapy makes U.S. debut at Glaucoma Center of San Francisco First U.S. patient receives Eyetronic nerve stimulation for glaucoma; early data expected 2026 as non-invasive therapy shows promise. bySoujanya RaviJuly 21, 2025